Targeting the molecular effects of a hypoxic tumor microenvironment

L Isabel Cardenas-Navia1, Rachel A Richardson, Mark W Dewhirst

  • 1Department of Biomedical Engineering, Duke University, Durham, NC, USA.

Insights

Tumor hypoxia, a challenge in cancer therapy, involves cellular responses affecting angiogenesis, invasion, and metabolism. Targeting multiple hypoxia-induced molecular pathways shows greater promise than single-pathway approaches for improved treatment outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Tumor hypoxia presents a significant obstacle in conventional solid tumor treatments.
  • Research is exploring strategies to modulate tumor oxygenation and the molecular consequences of hypoxia.

Purpose of the Study:

  • To examine cellular responses to hypoxia and their physiological impacts.
  • To review recent therapeutic strategies targeting hypoxia-induced molecular pathways.

Main Methods:

  • Review of literature on cellular responses to hypoxia.
  • Analysis of molecular pathways including angiogenesis, invasion, metastasis, apoptosis, and metabolism.
  • Evaluation of therapeutic interventions targeting these pathways.

Main Results:

  • Hypoxia influences key cancer processes such as angiogenesis, invasion, metastasis, apoptosis, and metabolism.
  • Targeting multiple downstream molecular pathways of hypoxia is more effective than single-pathway interventions.
  • Combination therapies require careful scheduling for optimal efficacy.

Conclusions:

  • Understanding and targeting hypoxia-driven molecular pathways is crucial for advancing cancer therapy.
  • Multimodal therapeutic strategies addressing multiple hypoxia-related pathways offer improved treatment potential.
  • Optimizing the integration of novel hypoxia-targeting agents with traditional therapies is essential.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...